Deutsche Bank’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-33,556
| Closed | -$335K | – | 3667 |
|
|
2025
Q2 | $335K | Sell |
33,556
-30
| -0.1% | -$242 | ﹤0.01% | 2671 |
|
|
2025
Q1 | $201K | Buy |
33,586
+21,055
| +168% | +$155K | ﹤0.01% | 2946 |
|
|
2024
Q4 | $96.2K | Sell |
12,531
-14,418
| -54% | -$124K | ﹤0.01% | 3295 |
|
|
2024
Q3 | $275K | Buy |
26,949
+5,908
| +28% | +$90.1K | ﹤0.01% | 2760 |
|
|
2024
Q2 | $312K | Sell |
21,041
-2,637
| -11% | -$37.8K | ﹤0.01% | 2573 |
|
|
2024
Q1 | $323K | Buy |
23,678
+389
| +2% | +$4.24K | ﹤0.01% | 2566 |
|
|
2023
Q4 | $255K | Sell |
23,289
-1,342
| -5% | -$13.3K | ﹤0.01% | 2742 |
|
|
2023
Q3 | $270K | Buy |
24,631
+2,552
| +12% | +$32.6K | ﹤0.01% | 2580 |
|
|
2023
Q2 | $292K | Sell |
22,079
-59,142
| -73% | -$843K | ﹤0.01% | 2670 |
|
|
2023
Q1 | $1.11M | Buy |
81,221
+7,216
| +10% | +$129K | ﹤0.01% | 2036 |
|
|
2022
Q4 | $1.45M | Buy |
74,005
+57,633
| +352% | +$1.13M | ﹤0.01% | 1840 |
|
|
2022
Q3 | $312K | Sell |
16,372
-583,459
| -97% | -$13.4M | ﹤0.01% | 2668 |
|
|
2022
Q2 | $12.4M | Sell |
599,831
-82,971
| -12% | -$1.97M | 0.01% | 926 |
|
|
2022
Q1 | $22M | Buy |
682,802
+670,533
| +5,465% | +$24.4M | 0.01% | 814 |
|
|
2021
Q4 | $571K | Sell |
12,269
-57,898
| -83% | -$1.93M | ﹤0.01% | 2752 |
|
|
2021
Q3 | $1.9M | Sell |
70,167
-417
| -0.6% | -$10.9K | ﹤0.01% | 2143 |
|
|
2021
Q2 | $1.81M | Sell |
70,584
-1,043
| -1% | -$24.9K | ﹤0.01% | 2322 |
|
|
2021
Q1 | $2.45M | Buy |
71,627
+63,653
| +798% | +$2.3M | ﹤0.01% | 2027 |
|
|
2020
Q4 | $270K | Buy |
7,974
+2,267
| +40% | +$60K | ﹤0.01% | 3296 |
|
|
2020
Q3 | $141K | Buy |
+5,707
| New | +$154K | ﹤0.01% | 3393 |
|
Other funds holding ITOS
Deutsche Bank's ITOS Position: Q3 2025 in Review
Deutsche Bank sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 33,556 shares — an estimated $335K sold.
Deutsche Bank first reported a position in ITOS in Q3 2020 and held it in 20 quarters. The position peaked at $22M in Q1 2022. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- Deutsche Bank reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- Deutsche Bank sold 33,556 iTeos Therapeutics shares in Q3 2025, an estimated $335K.
- Deutsche Bank first reported a position in iTeos Therapeutics in Q3 2020 and held it in 20 quarters.
- Deutsche Bank's iTeos Therapeutics position peaked at $22M in Q1 2022.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.